FDA Inspection 1207462 — Padagis US LLC
The FDA completed an inspection of Padagis US LLC on May 5, 2023 in Minneapolis, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 5, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Minneapolis, MN (United States)
Additional Details
Bioanalytical BA/BE